Skip to main content
OpenTrials
Completed

NCT Number: NCT03090386

Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients

This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–89 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • be between18 to 89 years old;
  • have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery)
  • have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study;
  • be native speakers of American English;
  • have obtained a minimum of a high school education;
  • self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; and
  • must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool.

Exclusion criteria

  • are younger than 18 years old or older than 89 years old;
  • have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery)
  • have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment;
  • are not native speakers of American English;
  • have not obtained a minimum of a high school education;
  • do not self-report at least one cognitive-linguistic or social-emotional deficit as assessed by the FACT-BR; or
  • do not demonstrate the capacity to sign informed consent

Treatment and study plan

Cognitive Surveys

Other

Complete the Cognitive Communication Survey, standardized cognitive and language assessments, and the Follow-up Cognitive Communication Survey after treatment

Primary outcomes

  1. Cognitive Communication Survey

    Time frame: 1 day at time of consent

    Survey is completed at time of consent

Secondary outcomes

  1. Cognitive-linguistic Standardized Testing

    Time frame: within 3 months of cognitive communication survey

    Standardized testing will be completed

  2. Follow-up Survey

    Time frame: within 6 months after completion of standardized testing

    Survey will be completed

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2017
Primary completion
2018
Study completion
2020
First posted
Mar 24, 2017
Registry last updated
Dec 1, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.